Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?

This article presents an overview of this area's current state, the conceivable opportunities and challenges of omics-based laboratory diagnostics, and a roadmap for improving MASLD biomarker research.PMID:38681130 | PMC:PMC11045490 | DOI:10.3748/wjg.v30.i14.1982

Source: World Journal of Gastroenterology - April 29, 2024 Category: Gastroenterology Authors: Julieta Trinks Mar ía F Mascardi Adri án Gadano Sebasti án Marciano Source Type: research